Pharmacotherapy of asthma.
The pharmacotherapy of asthma is a complex and evolving topic. A detailed understanding of the pathophysiologic processes involved in the asthmatic response forms the basis for understanding the actions of drugs used to treat this condition. Likewise, a solid comprehension of the medicinal chemistry and pharmacologic properties of the numerous agents involved in the treatment of asthma is critical for rationalizing drug choices and understanding potential side effects. Asthma is addressed at several points in the PharmD curriculum at South University including in the Pathophysiology (quarter 2), Integrated Sequence III (quarter 6), and Critical Care (quarter 9) courses. Various teaching strategies are employed throughout, along with weekly case-based recitations. The content presented here includes a synopsis of the pathophysiology and pharmacology from our Integrated Sequence III block on inflammatory diseases and asthma. A short review of pertinent pathophysiology is followed by a detailed presentation on the various classes of asthma drugs which includes their chemistry, mechanism of action, pharmacokinetics, toxicity, and interactions. This presentation is designed to prepare students for asthma therapeutics, which follows next in the schedule. The complexities of asthma pharmacotherapy are stressed along with current controversies and future drug development.
Zdanowicz
Martin M
MM
Department of Pharmaceutical Sciences, South University School of Pharmacy, Savannah, GA 31406, USA. mzdanowicz@southuniversity.edu
D000818:Animals; D018927:Anti-Asthmatic Agents / Q000378:metabolism / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000378:metabolism / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000378:metabolism; D003479:Curriculum; D004512:Education, Pharmacy / Q000379:methods; D006801:Humans
D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents